Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases

References

• Gibbs CJ Jr., Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM, Matthews WB. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 1968; 161:388 - 9; http://dx.doi.org/10.1126/science.161.3839.388; PMID: 5661299
   PubMed Web of Science ®Google Scholar
• Brown P, Gibbs CJ Jr., Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35:513 - 29; http://dx.doi.org/10.1002/ana.410350504; PMID: 8179297
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 44; http://dx.doi.org/10.1126/science.6801762; PMID: 6801762
   PubMed Web of Science ®Google Scholar
• Pan K-M, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 1993; 90:10962 - 6; http://dx.doi.org/10.1073/pnas.90.23.10962; PMID: 7902575
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363 - 83; http://dx.doi.org/10.1073/pnas.95.23.13363; PMID: 9811807
   PubMed Web of Science ®Google Scholar
• Prusiner SB, ed. Prion Biology and Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2004.
   Google Scholar
• Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr.. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem 1993; 268:20276 - 84; PMID: 8104185
   PubMed Web of Science ®Google Scholar
• Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 1991; 30:7672 - 80; http://dx.doi.org/10.1021/bi00245a003; PMID: 1678278
   PubMed Web of Science ®Google Scholar
• Oesch B, Westaway D, Wälchli M, McKinley MP, Kent SBH, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985; 40:735 - 46; http://dx.doi.org/10.1016/0092-8674(85)90333-2; PMID: 2859120
   PubMed Web of Science ®Google Scholar
• Caughey B, Baron GS, Chesebro B, Jeffrey M. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 2009; 78:177 - 204; http://dx.doi.org/10.1146/annurev.biochem.78.082907.145410; PMID: 19231987
   PubMed Web of Science ®Google Scholar
• Cobb NJ, Surewicz WK. Prion diseases and their biochemical mechanisms. Biochemistry 2009; 48:2574 - 85; http://dx.doi.org/10.1021/bi900108v; PMID: 19239250
   PubMed Web of Science ®Google Scholar
• Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930 - 6; http://dx.doi.org/10.1126/science.1138718; PMID: 17991853
   PubMed Web of Science ®Google Scholar
• Morales R, Abid K, Soto C. The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta 2007; 1772:681 - 91; http://dx.doi.org/10.1016/j.bbadis.2006.12.006; PMID: 17254754
   PubMed Web of Science ®Google Scholar
• Legname G, Baskakov IV, Nguyen H-OB, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB. Synthetic mammalian prions. Science 2004; 305:673 - 6; http://dx.doi.org/10.1126/science.1100195; PMID: 15286374
   PubMed Web of Science ®Google Scholar
• Castilla J, Saá P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell 2005; 121:195 - 206; http://dx.doi.org/10.1016/j.cell.2005.02.011; PMID: 15851027
   PubMed Web of Science ®Google Scholar
• Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 2009; 5:e1000421; http://dx.doi.org/10.1371/journal.ppat.1000421; PMID: 19436715
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132 - 5; http://dx.doi.org/10.1126/science.1183748; PMID: 20110469
   PubMed Web of Science ®Google Scholar
• Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A 2007; 104:9741 - 6; http://dx.doi.org/10.1073/pnas.0702662104; PMID: 17535913
   PubMed Web of Science ®Google Scholar
• Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S. Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog 2009; 5:e1000535; http://dx.doi.org/10.1371/journal.ppat.1000535; PMID: 19649330
   PubMed Web of Science ®Google Scholar
• Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, Race B, Qing L, Gambetti P, Caughey B, et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 2010; 285:14083 - 7; http://dx.doi.org/10.1074/jbc.C110.113464; PMID: 20304915
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT Jr., Caughey B. Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471 - 4; http://dx.doi.org/10.1038/370471a0; PMID: 7913989
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prion diseases and the BSE crisis. Science 1997; 278:245 - 51; http://dx.doi.org/10.1126/science.278.5336.245; PMID: 9323196
   PubMed Web of Science ®Google Scholar
• Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E, Prusiner SB, Tremblay P. Prion clearance in bigenic mice. J Gen Virol 2005; 86:2913 - 23; http://dx.doi.org/10.1099/vir.0.80947-0; PMID: 16186247
   PubMed Web of Science ®Google Scholar
• Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012; 11:618 - 28; http://dx.doi.org/10.1016/S1474-4422(12)70063-7; PMID: 22710755
   PubMed Web of Science ®Google Scholar
• Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P, Gelpi E, Giaccone G, Hauw JJ, Höftberger R, et al. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 2012; 124:517 - 29; http://dx.doi.org/10.1007/s00401-012-1002-8; PMID: 22744790
   PubMed Web of Science ®Google Scholar
• Safar JG. Molecular Mechanisms Encoding Quantitative and Qualitative Traits of Prion Strains. In: Gambetti P, ed. Prions and Diseases. New York: Springer Verlag, 2012.
   Google Scholar
• Safar JG. Molecular pathogenesis of sporadic prion diseases in man. Prion 2012; 6:108 - 15; http://dx.doi.org/10.4161/pri.18666; PMID: 22421210
   PubMed Web of Science ®Google Scholar
• Bessen RA, Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 1994; 68:7859 - 68; PMID: 7966576
   PubMed Web of Science ®Google Scholar
• Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, Mastrianni J, Lugaresi E, Gambetti P, Prusiner SB. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996; 274:2079 - 82; http://dx.doi.org/10.1126/science.274.5295.2079; PMID: 8953038
   PubMed Web of Science ®Google Scholar
• Safar J, Prusiner SB. Molecular studies of prion diseases. Prog Brain Res 1998; 117:421 - 34; http://dx.doi.org/10.1016/S0079-6123(08)64030-3; PMID: 9932423
   PubMed Web of Science ®Google Scholar
• Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in cell culture. Science 2010; 327:869 - 72; http://dx.doi.org/10.1126/science.1183218; PMID: 20044542
   PubMed Web of Science ®Google Scholar
• Kim C, Haldiman T, Surewicz K, Cohen Y, Chen W, Blevins J, Sy MS, Cohen M, Kong Q, Telling GC, et al. Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C). PLoS Pathog 2012; 8:e1002835; http://dx.doi.org/10.1371/journal.ppat.1002835; PMID: 22876179
   PubMedGoogle Scholar
• Kim C, Haldiman T, Cohen Y, Chen W, Blevins J, Sy MS, Cohen M, Safar JG. Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate. PLoS Pathog 2011; 7:e1002242; http://dx.doi.org/10.1371/journal.ppat.1002242; PMID: 21931554
   PubMedGoogle Scholar
• Haldiman T, Kim C, Cohen Y, Chen W, Blevins J, Qing L, Cohen ML, Langeveld J, Telling GC, Kong Q, et al. Co-existence of distinct prion types enables conformational evolution of human PrPSc by competitive selection. J Biol Chem 2013; 288:29846 - 61; http://dx.doi.org/10.1074/jbc.M113.500108; PMID: 23974118
   PubMed Web of Science ®Google Scholar
• Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, Serban A, Vey M, Baron H, Giles K, et al. Diagnosis of human prion disease. Proc Natl Acad Sci U S A 2005; 102:3501 - 6; http://dx.doi.org/10.1073/pnas.0409651102; PMID: 15741275
   PubMed Web of Science ®Google Scholar
• Safar JG, Scott M, Monaghan J, Deering C, Didorenko S, Vergara J, Ball H, Legname G, Leclerc E, Solforosi L, et al. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 2002; 20:1147 - 50; http://dx.doi.org/10.1038/nbt748; PMID: 12389035
   PubMed Web of Science ®Google Scholar
• Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157 - 65; http://dx.doi.org/10.1038/2654; PMID: 9771749
   PubMed Web of Science ®Google Scholar
• Uro-Coste E, Cassard H, Simon S, Lugan S, Bilheude JM, Perret-Liaudet A, Ironside JW, Haik S, Basset-Leobon C, Lacroux C, et al. Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 2008; 4:e1000029; http://dx.doi.org/10.1371/journal.ppat.1000029; PMID: 18389084
   PubMed Web of Science ®Google Scholar
• Yull HM, Ritchie DL, Langeveld JP, van Zijderveld FG, Bruce ME, Ironside JW, Head MW. Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol 2006; 168:151 - 7; http://dx.doi.org/10.2353/ajpath.2006.050766; PMID: 16400018
   PubMed Web of Science ®Google Scholar
• Schoch G, Seeger H, Bogousslavsky J, Tolnay M, Janzer RC, Aguzzi A, Glatzel M. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med 2006; 3:e14; http://dx.doi.org/10.1371/journal.pmed.0030014; PMID: 16354106
   PubMed Web of Science ®Google Scholar
• Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, Yuan J, Langeveld JP, Parchi P, Safar JG, Zou WQ, et al. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 2009; 132:2643 - 58; http://dx.doi.org/10.1093/brain/awp196; PMID: 19734292
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Mizukoshi K, Iwasaki Y, Miyata H, Yoshida Y, Kitamoto T. Co-occurrence of types 1 and 2 PrP(res) in sporadic Creutzfeldt-Jakob disease MM1. Am J Pathol 2011; 178:1309 - 15; http://dx.doi.org/10.1016/j.ajpath.2010.11.069; PMID: 21356381
   PubMed Web of Science ®Google Scholar
• Kimberlin RH, Walker CA. Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J Gen Virol 1978; 39:487 - 96; http://dx.doi.org/10.1099/0022-1317-39-3-487; PMID: 96212
   PubMed Web of Science ®Google Scholar
• Bruce ME, Fraser H. Scrapie strain variation and its implications. Curr Top Microbiol Immunol 1991; 172:125 - 38; http://dx.doi.org/10.1007/978-3-642-76540-7_8; PMID: 1810707
   PubMedGoogle Scholar
• Bruce ME. Scrapie strain variation and mutation. Br Med Bull 1993; 49:822 - 38; PMID: 8137131
   PubMed Web of Science ®Google Scholar
• Bessen RA, Marsh RF. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 1992; 73:329 - 34; http://dx.doi.org/10.1099/0022-1317-73-2-329; PMID: 1531675
   PubMed Web of Science ®Google Scholar
• Bessen RA, Marsh RF. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 1992; 66:2096 - 101; PMID: 1347795
   PubMed Web of Science ®Google Scholar
• Scott MR, Peretz D, Nguyen H-OB, Dearmond SJ, Prusiner SB. Transmission barriers for bovine, ovine, and human prions in transgenic mice. J Virol 2005; 79:5259 - 71; http://dx.doi.org/10.1128/JVI.79.9.5259-5271.2005; PMID: 15827140
   PubMed Web of Science ®Google Scholar
• Scott M, Peretz D, Ridley RM, Baker HF, DeArmond SJ, Prusiner SB. Transgenetic investigations of the species barrier and prion strains. In: Prusiner SB, ed. Prion Biology and Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2004:435-82.
   Google Scholar
• Govaerts C, Wille H, Prusiner SB, Cohen FE. Structural studies of prion proteins. In: Prusiner SB, ed. Prion Biology and Diseases. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2004:243-82.
   Google Scholar
• Mahal SP, Baker CA, Demczyk CA, Smith EW, Julius C, Weissmann C. Prion strain discrimination in cell culture: the cell panel assay. Proc Natl Acad Sci U S A 2007; 104:20908 - 13; http://dx.doi.org/10.1073/pnas.0710054104; PMID: 18077360
   PubMed Web of Science ®Google Scholar
• Castilla J, Morales R, Saá P, Barria M, Gambetti P, Soto C. Cell-free propagation of prion strains. EMBO J 2008; 27:2557 - 66; http://dx.doi.org/10.1038/emboj.2008.181; PMID: 18800058
   PubMed Web of Science ®Google Scholar
• Bishop MT, Will RG, Manson JC. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 2010; 107:12005 - 10; http://dx.doi.org/10.1073/pnas.1004688107; PMID: 20547859
   PubMed Web of Science ®Google Scholar
• Korth C, Kaneko K, Groth D, Heye N, Telling G, Mastrianni J, Parchi P, Gambetti P, Will R, Ironside J, et al. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A 2003; 100:4784 - 9; http://dx.doi.org/10.1073/pnas.2627989100; PMID: 12684540
   PubMed Web of Science ®Google Scholar
• Bartz JC, Kramer ML, Sheehan MH, Hutter JA, Ayers JI, Bessen RA, Kincaid AE. Prion interference is due to a reduction in strain-specific PrPSc levels. J Virol 2007; 81:689 - 97; http://dx.doi.org/10.1128/JVI.01751-06; PMID: 17079313
   PubMed Web of Science ®Google Scholar
• Bartz JC, Aiken JM, Bessen RA. Delay in onset of prion disease for the HY strain of transmissible mink encephalopathy as a result of prior peripheral inoculation with the replication-deficient DY strain. J Gen Virol 2004; 85:265 - 73; http://dx.doi.org/10.1099/vir.0.19394-0; PMID: 14718642
   PubMed Web of Science ®Google Scholar
• Shikiya RA, Ayers JI, Schutt CR, Kincaid AE, Bartz JC. Coinfecting prion strains compete for a limiting cellular resource. J Virol 2010; 84:5706 - 14; http://dx.doi.org/10.1128/JVI.00243-10; PMID: 20237082
   PubMed Web of Science ®Google Scholar
• Manuelidis L, Lu ZY. Virus-like interference in the latency and prevention of Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 2003; 100:5360 - 5; http://dx.doi.org/10.1073/pnas.0931192100; PMID: 12692308
   PubMed Web of Science ®Google Scholar
• Oelschlegel AM, Weissmann C. Acquisition of drug resistance and dependence by prions. PLoS Pathog 2013; 9:e1003158; http://dx.doi.org/10.1371/journal.ppat.1003158; PMID: 23408888
   PubMed Web of Science ®Google Scholar
• Cummings JL. Biomarkers in Alzheimer’s disease drug development. Alzheimers Dement 2011; 7:e13 - 44; http://dx.doi.org/10.1016/j.jalz.2010.06.004; PMID: 21550318
   PubMedGoogle Scholar
• Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011; 70:960 - 9; http://dx.doi.org/10.1097/NEN.0b013e318232a379; PMID: 22002422
   PubMed Web of Science ®Google Scholar
• Hardy J. Has the amyloid cascade hypothesis for Alzheimer’s disease been proved?. Curr Alzheimer Res 2006; 3:71 - 3; http://dx.doi.org/10.2174/156720506775697098; PMID: 16472206
   PubMedGoogle Scholar
• Schellenberg GD, Montine TJ. The genetics and neuropathology of Alzheimer’s disease. Acta Neuropathol 2012; 124:305 - 23; http://dx.doi.org/10.1007/s00401-012-0996-2; PMID: 22618995
   PubMed Web of Science ®Google Scholar
• Schmidt C, Wolff M, Weitz M, Bartlau T, Korth C, Zerr I. Rapidly progressive Alzheimer disease. Arch Neurol 2011; 68:1124 - 30; http://dx.doi.org/10.1001/archneurol.2011.189; PMID: 21911694
   PubMed Web of Science ®Google Scholar
• Wilkosz PA, Seltman HJ, Devlin B, Weamer EA, Lopez OL, DeKosky ST, Sweet RA. Trajectories of cognitive decline in Alzheimer’s disease. Int Psychogeriatr 2010; 22:281 - 90; http://dx.doi.org/10.1017/S1041610209991001; PMID: 19781112
   PubMed Web of Science ®Google Scholar
• McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7:263 - 9; http://dx.doi.org/10.1016/j.jalz.2011.03.005; PMID: 21514250
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K. Evolutional aspects of Alzheimer’s disease pathogenesis. J Alzheimers Dis 2013; 33:Suppl 1 S155 - 61; PMID: 22699850
   PubMedGoogle Scholar
• Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, et al, Alzheimer’s Disease Neuroimaging Initiative. The Alzheimer’s Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement 2012; 8:Suppl S1 - 68; http://dx.doi.org/10.1016/j.jalz.2011.09.172; PMID: 22047634
   PubMed Web of Science ®Google Scholar
• Ashe KH, Aguzzi A. Prions, prionoids and pathogenic proteins in Alzheimer disease. Prion 2013; 7:55 - 9; http://dx.doi.org/10.4161/pri.23061; PMID: 23208281
   PubMed Web of Science ®Google Scholar
• Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 2012; 71:362 - 81; http://dx.doi.org/10.1097/NEN.0b013e31825018f7; PMID: 22487856
   PubMed Web of Science ®Google Scholar
• Schmidt C, Artjomova S, Hoeschel M, Zerr I. CSF prion protein concentration and cognition in patients with Alzheimer disease. Prion 2013; 7:229 - 34; http://dx.doi.org/10.4161/pri.23904; PMID: 23406922
   PubMed Web of Science ®Google Scholar
• Schmidt C, Haïk S, Satoh K, Rábano A, Martinez-Martin P, Roeber S, Brandel JP, Calero-Lara M, de Pedro-Cuesta J, Laplanche JL, et al. Rapidly progressive Alzheimer’s disease: a multicenter update. J Alzheimers Dis 2012; 30:751 - 6; PMID: 22460329
   PubMed Web of Science ®Google Scholar
• Schmidt C, Redyk K, Meissner B, Krack L, von Ahsen N, Roeber S, Kretzschmar H, Zerr I. Clinical features of rapidly progressive Alzheimer’s disease. Dement Geriatr Cogn Disord 2010; 29:371 - 8; http://dx.doi.org/10.1159/000278692; PMID: 20453509
   PubMed Web of Science ®Google Scholar
• Chitravas N, Jung RS, Kofskey DM, Blevins JE, Gambetti P, Leigh RJ, Cohen ML. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol 2011; 70:437 - 44; http://dx.doi.org/10.1002/ana.22454; PMID: 21674591
   PubMed Web of Science ®Google Scholar
• Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC. Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci 2000; 20:3606 - 11; PMID: 10804202
   PubMed Web of Science ®Google Scholar
• Guo JL, Lee VM. Neurofibrillary tangle-like tau pathology induced by synthetic tau fibrils in primary neurons over-expressing mutant tau. FEBS Lett 2013; 587:717 - 23; http://dx.doi.org/10.1016/j.febslet.2013.01.051; PMID: 23395797
   PubMed Web of Science ®Google Scholar
• Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006; 313:1781 - 4; http://dx.doi.org/10.1126/science.1131864; PMID: 16990547
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Cell biology. A unifying role for prions in neurodegenerative diseases. Science 2012; 336:1511 - 3; http://dx.doi.org/10.1126/science.1222951; PMID: 22723400
   PubMed Web of Science ®Google Scholar
• Colom LV, Perry G, Kuljis RO. Tackling the elusive challenges relevant to conquering the 100-plus year old problem of Alzheimer’s disease. Curr Alzheimer Res 2013; 10:108 - 16; PMID: 23368433
   PubMed Web of Science ®Google Scholar